Re: prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes

Comment

Steven A Kaplan. J Urol. 2013 Apr.

. 2013 Apr;189(4):1450.

doi: 10.1016/j.juro.2012.12.087. Epub 2013 Jan 3.

No abstract available

Comment on

Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
Sherman JJ, Welch RW, Hill TM, McEwen C. Sherman JJ, et al. J Pharm Pract. 2012 Apr;25(2):164-8. doi: 10.1177/0897190011431634. Epub 2012 Jan 3. J Pharm Pract. 2012. PMID: 22215645

Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
Sherman JJ, Welch RW, Hill TM, McEwen C. Sherman JJ, et al. J Pharm Pract. 2012 Apr;25(2):164-8. doi: 10.1177/0897190011431634. Epub 2012 Jan 3. J Pharm Pract. 2012. PMID: 22215645
Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
Nichol MB, Knight TK, Wu J, Barron R, Penson DF. Nichol MB, et al. J Urol. 2009 May;181(5):2214-21; discussion 2221-2. doi: 10.1016/j.juro.2009.01.033. Epub 2009 Mar 17. J Urol. 2009. PMID: 19296986
Consultation patterns in a community survey of men with benign prostatic hyperplasia.
Simpson RJ, Lee RJ, Garraway WM, King D, McIntosh I. Simpson RJ, et al. Br J Gen Pract. 1994 Nov;44(388):499-502. Br J Gen Pract. 1994. PMID: 7538316 Free PMC article.
Translation of benign prostatic hyperplasia guidelines into clinical practice.
Gravas S, Tzortzis V, Melekos MD. Gravas S, et al. Curr Opin Urol. 2008 Jan;18(1):56-60. doi: 10.1097/MOU.0b013e3282f13bbf. Curr Opin Urol. 2008. PMID: 18090491 Review.
Managing patients with benign prostatic hyperplasia.
Hicks RJ, Cook JB. Hicks RJ, et al. Am Fam Physician. 1995 Jul;52(1):135-42, 145-6. Am Fam Physician. 1995. PMID: 7541601 Review.